Active substance
Results for the substance emtricitabine
2 results
About this active substance
Emtricitabine is an antiviral medication used in the treatment of HIV-1 infection and, in some cases, for its prevention (pre-exposure prophylaxis, PrEP). It belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs) and works by blocking the reverse transcriptase enzyme, which is essential for HIV replication.
This medication is commonly used in combination with other antivirals, as monotherapy is not sufficient to control HIV infection. Emtricitabine is included in several combination therapy regimens, often as a single-tablet formulation, to simplify treatment and improve patient adherence.
Emtricitabine is typically taken once daily, with or without food. It is important for patients to strictly follow the prescribed treatment regimen to prevent the development of viral resistance and to maintain viral load at undetectable levels.
The side effects of emtricitabine are generally mild and include headache, nausea, fatigue, or changes in skin color (hyperpigmentation, particularly on the palms or soles). In rare cases, more serious adverse effects, such as lactic acidosis or liver dysfunction, may occur.
Although emtricitabine does not cure HIV infection, its proper use, in combination with other antiretroviral medications, helps suppress the virus, reduce the risk of transmission, and improve patients' quality of life. Regular medical check-ups are essential to monitor the effectiveness of the treatment.
This medication is commonly used in combination with other antivirals, as monotherapy is not sufficient to control HIV infection. Emtricitabine is included in several combination therapy regimens, often as a single-tablet formulation, to simplify treatment and improve patient adherence.
Emtricitabine is typically taken once daily, with or without food. It is important for patients to strictly follow the prescribed treatment regimen to prevent the development of viral resistance and to maintain viral load at undetectable levels.
The side effects of emtricitabine are generally mild and include headache, nausea, fatigue, or changes in skin color (hyperpigmentation, particularly on the palms or soles). In rare cases, more serious adverse effects, such as lactic acidosis or liver dysfunction, may occur.
Although emtricitabine does not cure HIV infection, its proper use, in combination with other antiretroviral medications, helps suppress the virus, reduce the risk of transmission, and improve patients' quality of life. Regular medical check-ups are essential to monitor the effectiveness of the treatment.
-
-
EMTRIVA 10mg/ml oral solution GILEAD ORIGINAL MEDICINE